ArticleThe Journal of antimicrobial chemotherapy2025

TDM-guided meropenem/vaborbactam-based therapy for successful treatment of intra-abdominal and bloodstream infection caused by KPC-producing ceftazidime/avibactam-resistant Klebsiella pneumoniae in a paediatric liver transplant recipient.

Giovanni Mulé et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.